157 related articles for article (PubMed ID: 16265126)
1. Drug Insight: appetite suppressants.
Bray GA
Nat Clin Pract Gastroenterol Hepatol; 2005 Feb; 2(2):89-95. PubMed ID: 16265126
[TBL] [Abstract][Full Text] [Related]
2. The development of tolerance to drugs that suppress food intake.
Fernstrom JD; Choi S
Pharmacol Ther; 2008 Jan; 117(1):105-22. PubMed ID: 17950459
[TBL] [Abstract][Full Text] [Related]
3. Anesthetic considerations for the new antiobesity medications.
Jeffers LA
AANA J; 1996 Dec; 64(6):541-4. PubMed ID: 9204789
[TBL] [Abstract][Full Text] [Related]
4. Drug strategies for the treatment of obesity.
Alemany M; Remesar X; Fernández-López JA
IDrugs; 2003 Jun; 6(6):566-72. PubMed ID: 12811679
[TBL] [Abstract][Full Text] [Related]
5. Neuropharmacology of human appetite expression.
Halford JC; Harrold JA
Dev Disabil Res Rev; 2008; 14(2):158-64. PubMed ID: 18646016
[TBL] [Abstract][Full Text] [Related]
6. Drug treatment of obesity.
Bray GA
Baillieres Best Pract Res Clin Endocrinol Metab; 1999 Apr; 13(1):131-48. PubMed ID: 10932681
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacological, toxicological, deontologic, and medico-legal aspects of the use of appetite suppressant agents in "weight-loss cures"].
Carolei L; Ermio G; Accorinti N; Meo G; Lamberti V; De Sarro G
Minerva Med; 1997; 88(7-8):317-26. PubMed ID: 9304076
[TBL] [Abstract][Full Text] [Related]
8. Fluoxetine increases the anorectic and long-term dopamine-depleting effects of phentermine.
Callahan BT; Yuan J; Ricaurte GA
Synapse; 2000 Dec; 38(4):471-6. PubMed ID: 11044894
[TBL] [Abstract][Full Text] [Related]
9. Sibutramine-induced anorexia: potent, dose-dependent and behaviourally-selective profile in male rats.
Tallett AJ; Blundell JE; Rodgers RJ
Behav Brain Res; 2009 Mar; 198(2):359-65. PubMed ID: 19061919
[TBL] [Abstract][Full Text] [Related]
10. Appetite suppressants. A review.
Silverstone T
Drugs; 1992 Jun; 43(6):820-36. PubMed ID: 1379155
[TBL] [Abstract][Full Text] [Related]
11. Locomotion is the major determinant of sibutramine-induced increase in energy expenditure.
Golozoubova V; Strauss F; Malmlöf K
Pharmacol Biochem Behav; 2006 Apr; 83(4):517-27. PubMed ID: 16647108
[TBL] [Abstract][Full Text] [Related]
12. New findings on the neuropharmacological control of food intake.
Carruba MO; Ricciardi S; Müller EE; Mantegazza P
Pharmacol Res Commun; 1980 Jun; 12(6):599-603. PubMed ID: 6105681
[No Abstract] [Full Text] [Related]
13. The amphetamine appetite suppressant saga.
Prescrire Int; 2004 Feb; 13(69):26-9. PubMed ID: 15055225
[TBL] [Abstract][Full Text] [Related]
14. A concise review on the therapeutics of obesity.
Bray GA
Nutrition; 2000 Oct; 16(10):953-60. PubMed ID: 11054601
[TBL] [Abstract][Full Text] [Related]
15. Effect of isocaloric diets and sibutramine on food intake, body mass variation and serum TNF-alpha levels in rats.
Trapali M; Liapi C; Perelas A; Perrea D; Stroubini T; Dontas I; Couvari E; Mavri M; Galanopoulou P
Pharmacology; 2008; 82(1):15-21. PubMed ID: 18434760
[TBL] [Abstract][Full Text] [Related]
16. Effects of sibutramine on the appetitive and consummatory aspects of feeding in non-human primates.
Foltin RW
Physiol Behav; 2006 Feb; 87(2):280-6. PubMed ID: 16352322
[TBL] [Abstract][Full Text] [Related]
17. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success.
Elfhag K; Finer N; Rössner S
Diabetes Obes Metab; 2008 Jun; 10(6):498-505. PubMed ID: 17593239
[TBL] [Abstract][Full Text] [Related]
18. Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats.
Roth JD; Trevaskis JL; Wilson J; Lei C; Athanacio J; Mack C; Kesty NC; Coffey T; Weyer C; Parkes DG
Int J Obes (Lond); 2008 Aug; 32(8):1201-10. PubMed ID: 18560368
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of appetite suppression.
Halford JC; Blundell JE
Prog Drug Res; 2000; 54():25-58. PubMed ID: 10857385
[TBL] [Abstract][Full Text] [Related]
20. Neurochemical mechanism of action of anorectic drugs.
Samanin R; Garattini S
Pharmacol Toxicol; 1993 Aug; 73(2):63-8. PubMed ID: 7902561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
